LPL Financial’s Tyra Biosciences TYRA Stock Holding History

LPL Financial’s Portfolio TYRA Stock Details TYRA Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q1	–	Sell	-10,500	Closed	-$145K	–	5026
2023 Q4	$145K	Sell	10,500 -4,000	-28%	-$51.8K	﹤0.01%	4474
2023 Q3	$200K	Sell	14,500 -5,000	-26%	-$74.1K	﹤0.01%	4244
2023 Q2	$332K	Hold	19,500	–	–	﹤0.01%	3763
2023 Q1	$313K	Sell	19,500 -500	-3%	-$5.95K	﹤0.01%	3705
2022 Q4	$152K	Hold	20,000	–	–	﹤0.01%	4064
2022 Q3	$176K	Sell	20,000 -500	-2%	-$4.57K	﹤0.01%	3985
2022 Q2	$147K	Buy	+20,500	New	+$163K	﹤0.01%	4033

Other funds holding TYRA

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Boxer Capital San Diego, California $2.04B AUM 108.39% 1-Year Est. Return

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

CPX

Canaan Partners XI Menlo Park, California $76.1M AUM 638.59% 1-Year Est. Return

Nextech Invest Zurich, Switzerland $1.42B AUM 304.47% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

TCM

TCG Crossover Management Palo Alto, California $3.5B AUM 1,165.83% 1-Year Est. Return

FFM

Fairmount Funds Management West Conshohocken, Pennsylvania $1.38B AUM 407.79% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

5VM

5AM Venture Management San Francisco, California $360M AUM 345.76% 1-Year Est. Return

LPL Financial's TYRA Position: Q1 2024 in Review

LPL Financial sold out of Tyra Biosciences (TYRA) in Q1 2024, closing a stake of 10,500 shares — an estimated $145K sold.

LPL Financial first reported a position in TYRA in Q2 2022 and held it in 7 quarters. The position peaked at $332K in Q2 2023. 77 funds tracked by Wall St. Rank hold TYRA as of Q1 2024.

LPL Financial reported no remaining Tyra Biosciences position as of Q1 2024 after selling out during the quarter.
LPL Financial sold 10,500 Tyra Biosciences shares in Q1 2024, an estimated $145K.
LPL Financial first reported a position in Tyra Biosciences in Q2 2022 and held it in 7 quarters.
LPL Financial's Tyra Biosciences position peaked at $332K in Q2 2023.
77 funds tracked by Wall St. Rank held Tyra Biosciences as of Q1 2024.

Based on LPL Financial's 13F filing for Q1 2024, filed 10 May 2024.